Bruce C. Cozadd, Chairman & CEO at Jazz Pharmaceuticals plc (JAZZ), sold 3,000 shares at $159.59 ($480K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Seasonal sale ($480k) by Chairman & CEO — this insider has traded JAZZ in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.59 | 1,000 | $160K | 33.3% |
| 2 | $160.00 | 2,000 | $320K | 66.7% |
| Total | $159.86 avg | 3,000 | $480K | 100% |
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |